Complicaciones neurológicas en pacientes con linfomas

Revista Cubana de Medicina

Volumn 39, Issue 2, 2000, Pages 75-87

  Gómez Viera, Nelson ^a   Monteagudo Torres, Marisol ^a   De Castro Arenas, Raúl ^a   Ruiz García, Dania ^a  

^a HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 52849096996     PISSN: 00347523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Marshall A. Lymphocytic disorder malignat proliferative response lymphoma. En: Williams WJ. Hematology. 3 ed. New York:Mc Graw-Hill, 1984:1003-25.
2. Lawrence DR. Neurologic complications of systemic lymphoma. Neurol Clins 1991;9:1001-11.
3. Cabanillas F, Litam JP, Smith TL. Central nervous system relapse in malignant lymphomas: Risk factor and implications for profilaxis. Blood 1979;45:1249-57.
4. García A, Gelabert M, García-Allut A. Linfomas primarios del sistema nervioso central: revisión de la casuística. Revista de Neurología 1998;27(158):577-81.
5. Kelly KK, Smirniotopoulos JP, Jones RV. Primary central nervous system lymphoma: Radiologic-Pathologic correlation. Radiographic 1997;17(6):1497-526.
6. Landys KE, Berg EB, Torgenson JS, Johansson BR. Bulky centroblastic non-Hodgkin's lymphoma of the cranium vault mimicking brain involvement managed with chemotherapy. Cancer 1995;76(7):1261-7.
7. García-Rayo S, Martínez-Monge R, Brugarolas A. Respuesta a la quimioterapia en el linfoma primario cerebral. Revista de Neurología 1998;27(160):992-4.
8. Lowenthal DA, Straus DJ, Campbell SW. AIDS-related lymphoid neoplasia. Cancer 1998;61:2325-32.
9. Monserrat E, Bosch F, Graus F, Terol MJ. CNS involvement in mantle-cell lymphoma. J Clin Oncol 1996;14(3):941-4.
10. Formaglio F, Caraceni A. Meningeal metastases: Clinical aspects and diagnosis. Italian Journal of Neurological Sciences 1998;19(3):133-49.
11. Elliot P, Ku NN, Werner MH. Neoplastic meningitis with normal neurological findings: Magnetic resonance imaging results. J Neuroimaging 1995;5(4):233-6.
12. Sakai C, Takagi T, Wakatsuki S. Primary meningeal lymphoma presenting solely with blindness. A report of an autopsy case. Int J Hematol 1996;63(4):325-9.
13. Salvati M, Cervoni L, Raco A, Delfini R, Ciappetta P. Primary spinal non-Hodgkin's lymphoma: a clinical study. Surg Neurol 1996;46(4):339-43.
14. Perry JR, Deodhare SS, Bilbao JM, Murray D, Muller P. The significance of compression as the initial manifestation of lymphoma. Neurosurgery 1993;(2): 157-62.
15. Narberhaus B, Buxo J, Forcadas P, García B. Linfoma dural primario. Rev Neurol 1996;11(3):117-9.
16. Petiot P, Croisile B, Vighetto A, Bret P, Trillet M. An aspect of intracerebral lymphoma in scanner x mimicking meningioma. Rev Neurol Paris 1995;151(10):580-2.
17. Gemignani F, Marchesi G, Giovanni G, Quaini F. Low-grade non-Hodgkin B-cell lymphoma presenting as sensory neuropathy. Eur Neurol 1996;36(3):138-41.
18. Barth P, Roegel C, Flumio F, Geisler F. Subacute distal motor neuropathy disclosing malignant non-Hodgkin's lymphoma: improvement under chemotheraphy. Rev Neurol Paris 1996;152(3):208-10.
19. Cancelas JA, López-Jimenez J, González C, Calbo MA. Cerebral toxoplasmosis with atypical presentation in a bone marrow transplant patient. Med-Clin-Bar 1994;103(10):383-4.
20. Rockman CB, Riles TS, Fisher FS, Adelman FS, Lamparello PJ. The surgical management of carotid artery stenosis with previous neck irradiation. Am J Surg 1996;172(2):191-5.
21. García TJ, Ferris J, Menor F. Intrathecal chemotherapy-related myeloencephalopathy in a young child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1995;12(4):377-85.
22. Beretta F, Sanna P, Guielmini M, Cavalli F. Paraplegia following intrathecal chemotherapy. Schweiz Med Wochenschr 1996;126(25):1107-11.
23. Rubie H, Guillot S, Netter JC, Le Tallec C, Voig JJ, Olives JP. Acute hepatopathy compatible with Reye's syndrome in 3 children treated by chemotherapy. Arch Pediatr 1994;1(6):573-7.
24. Vogel H, Horoupian DS. Filamentous degeneration of neurons: A possible feature of cytosine arabinoside neurotoxicity. Cancer 1993;71(4):1303-8.
25. Harris GJ, Murphy ML, Schmidt EV, Dotson RM. Orbital myositis as a paraneoplastic syndrome. Arch Ophthalmol 1994;112(3):380-6.
26. Sarmiento Castillo R. Manifestaciones neurológicas de los linfomas. Rev Cubana Med 1985;10(2):15-9.
27. Non-Hodgkin's Lymphoma Pathologic Classification Projet National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphoma: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-35.
28. Kaplan El, Meier P. Non-parametric estimations from incomplete observations. J Am Stat Assoc 1958;53:547-82.
29. Lyons MK, O'neill BP, Kurtin PJ, Marsh WR. Diagnosis and management of primary spinal epidural non-Hodgkin's lymphoma. Mayo Clin Proc 1996;71:453-7.
30. Smith TL, Pérez RS, Cabanillas F. Central nervous system prophylaxis with combined intravenous and intrathecal methotrexate in diffuse lymphoma of agressive histologic type. Cancer 1986;57:971-7.
31. Heffner R. Pathology of the nervous system. En: Bradley GW. Neurology in clinical practice. USA:Butterworth-Heinemann, 1991:991-1006.
32. Litam JP, Cabanillas F, Smith TL. Central nervous system relapse in malignant lymphomas: Risk factor and implications for profilaxis. Blood 1979;45:1249-57.
33. Ferreri AJ, Reni M, Zoldan MC, Terreni MR, Villa E. Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion. Cancer 1996;77(5):827-33.
34. Mackintosh FR, Colby TV, Podolski WJ, Burke JS, Hoppe RI, Rosenfelt FP, et al. Central nervous system involvement in non-Hodgkin's lymphoma: An analysis of 105 cases. Cancer 1982;49:586-95.
35. Herman TS, Hammond N, Jones ES, Butler JJ, Byrne GE. Involvement of the central nervous system by non-Hodgkin's lymphoma. Cancer 1979;43:390-7.
36. Haerni GS, Suchaud JP, Eghbali H, Coindre JM. Secondary involvement of the central nervous system in malignant non-Hodgkin's lymphoma. Oncology 1987;44:98-101.
37. Bollen EL, Brouwer RE, Hamers S, Hermans J, Kluin M. Central nervous system relapse in non-Hodgkin's lymphoma: A single center study of 532 patients. Arch Neurol 1997;54(7):854-9.
38. Nowacki P, Fryze C, Zyluk B. Central nervous system leukostasis in patients with leukemias and lymphomas. Folia Neuropathol 1995;33(1):59-65.
39. Koeller K, Smirniotopoulos J, Jones R. Primary central nervous system lymphoma: radiologic-pathologic correlation. From the Archives of the AFIP. Radiographics 1997;17:1497-526.
40. Goffinet DR, Glatstein EJ, Merigan TC. Herpes zoster-varicella infections and lymphoma. Ann Inter Med 1972;76:235-9.
41. Hughes BA, Kimmel DW, Aksamit AJ. Herpes zoster associated meningoencephalitis in patients with systemic cancer. Mayo-Clin-Proc 1993;68(7):652-5.
42. Zyluk B, Nowacki P. Lymphomatous infiltrates within leptomeninges and spinal root in adult patients with non-Hodgkin's lymphoma after intrathecal methotrexate administration. Folia Neuropathol 1996;34(2):113-8.
43. Schuknecht B, Huber P, Buller B, Nadjimi M. Spinal leptomeningeal neoplastic disease: Evalution by MR, myelography and CT myelography. Eur Neurol 1992;32(1):11-6.
44. Kersten MJ, Evers LM, Dellemijn PL, Portegies P. Elevation of cerebrospinal fluid soluble CD-27 levels in patients with meningeal localization of lymphoid malignancies. Blood 1996;87(5):1985-9.
45. Jaeckle KA. Clinical presentation and therapy of nervous system tumors. En: Bradley GW. Neurology in clinical practice. USA:Butterworth-Heinemann, 1991:1008-29.
46. Rhodes CH, Glantz MJ, Lekos A. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 1996;77(3):543-8.
47. Levitt LJ, Dawson DM, Rosenthal DS. CNS involvement in the non-Hodgkin's lymphomas. Cancer 1980;45:545-50.
48. Grant JW, Kaech D, Jones DB. Spinal cord compression as the first presentation of lymphoma: A review of 15 cases. Histopathology 1986;10:1191-202.
49. Haddad P, Tharell JF, Kiely JM, Harrison EG, Miller RH. Lymphoma of the spinal extradural space. Cancer 1976;38:1862-6.
50. Wong ET, Portlock CS, O'Brien JP, De Angelis LM. Chemosensitive epidural spinal cord disease in non-Hodgkin's lymphoma. Neurolgoy 1996;46(6):1543-7.
51. Kim RY, Smith JW, Spencer SA, Meredith RF, Salter MM. Malignant epidural spinal cord compresion associate with a paravertebral mass: Its radiotherapeutic outcome on radiosensitivity. Int J Radiat Oncol Biol Phys 1993;27(5):1079-83.
52. Friedman M, Kim TH, Panahon AM. Spinal cord compression in malignant lymphoma:Treatment and results. Cancer 1976;37:1485-91.
53. Rogers LR, Posner JM. Cerebrovascular complications in patients with cancer. Cancer 1987;60:1452-63.
54. Ginsberg LE, Leeds EN. Neuroradiology of leukemias. AJR 1995;165:525-34.
55. Graus F, Rogers LR, Posner LB. Cerebrovascular complications in patients with cancer. Medicine 1985;64:16-35.
56. Ahsildar HI, Remler BF, Creger RJ, Cooper BW. Delayed transient encephalopathy after marrow transplantation: Case reports and MRI findings in four patients. J Neur. Oncol 1996;27(3):241-50.
57. Tomura N, Sashi R, Hashimoto M, Hirano H, Sato K, Watarai J. MRI abnormalities of the brain in neurologic complications following treatment of cancer in children. No To Shinkei 1996;48(7):623-30.
58. Walsh JC. Neuropathy associated with lymphoma. J Neurol Neurosurg Psychiatry 1971;34:42-50.
59. Bilinska M, Usnarka L, Ejma M, Martynow R. Polyneuropathy in non-Hodgkin's lymphoma. Neurol Neurochir Pol 1995;29(3):343-52.
60. Van-der-Bent MJ, de-Bruin HG, Beun GB, Vecht CJ. Neurolymphomatosis of the median nerve. Neurology 1995;45(7):1403-5.
61. Ellie E, Vital A, Steck AJ, Vital C. High-grade B-cell cerebral lymphoma in a patient with anti-myelin-associated glycoprotein IgM paraproteinemic neuropathy. Neurology 1995;45(2):378-81.
62. Warzocha K, Krykowks E, Gora-Tybor J, Robak T. Fulminant 2-chlorodeoxyadenosine-related peripheral neuropathy in a patient with paraneoplastic neurological syndrome associated with lymphoma. Leuk-Lym 1996;21(3-4):343-6.
63. Lisak RP, Mictchell M, Zweiman B. Guillain-Barre syndrome and Hodgkin's disease: 3 cases with inmunological studies. Ann Neurol 1977;1:72-6.
64. Vallat JM, Mascarel HA, Bordessoule D, Gelot A. Non-Hodgkin's malignant lymphomas and peripheral neuropathies-13 cases. Brain 1995; 118(5):1233-45.
65. Chalk CH, Windebank AJ, Kimmel DW. The distinctive clinical features of paraneoplastic sensory neuronopathy. Can J Neurol Sci 1992;19:346-50.
66. Hammack J, Kotanides H, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: Clinical and inmunologic findings in 21 patients with Hodgkin's disease. Neurology 1992;42(10):1938-42.
67. Campello Y, Moreno E, Capablo JL, Castellanos P. Miastenia gravis y linfoma no Hodgkin. Neurologia 1995;10(6):246-8.
68. Argov Z, Shapira Y, Averbuch HL, Wirguin I. Lambert-Eaton Myasthenic syndrome in association with lymphoproliferative disorders. Muscle-Nerve 1995;18(7):715-9.
69. Posner JB. Paraneoplastic syndromes. Neurol Clin 1991;9:919-23.
70. Gottieb D, Bradstock K. The neurotoxicity of high-dose cytosine arabinoside is aged-related. Cancer 1987;60:1439-42.
71. Fallovollita J, Bleyer A. Intellectual dysfunction after cranial irradiation in young children with lymphoma. Pro Am Soc Clin Oncol 1987;6:257-62.
72. Recht L, Straus DJ, Cirrincione C. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis. Am J Med 1988;84:425-38.
73. Murphy S, Ha CS, Romaguera J, Forman A, Cabanillas F. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate- grade and inmunoblastic lymphoma. Blood 1998;91(4):1178-84.